Pembrolizumab
26-X026
Phase 2 mab active
Quick answer
Pembrolizumab for Head and Neck Squamous Cell Carcinoma is a Phase 2 program (mab) at Bicara Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bicara Therapeutics
- Indication
- Head and Neck Squamous Cell Carcinoma
- Phase
- Phase 2
- Modality
- mab
- Status
- active